Clinical Trial Update: Effect of Losartan on Retinal Endothelial Function in Patients With Essential Hypertension [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial evaluating losartan on retinal endothelial function in patients with essential hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Hypertension | Phase 2, Phase 3 | Status: WITHDRAWN